EMFAT
Emerald Mutual Fund Advisers Trust’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-243,795
| Closed | -$8.29M | – | 219 |
|
|
2024
Q3 | $8.29M | Buy |
243,795
+116,832
| +92% | +$3.97M | 0.43% | 78 |
|
|
2024
Q2 | $4.7M | Hold |
126,963
| – | – | 0.25% | 105 |
|
|
2024
Q1 | $5.33M | Buy |
+126,963
| New | +$5.33M | 0.28% | 105 |
|
|
2013
Q4 | – | Sell |
-223,412
| Closed | -$7.92M | – | 224 |
|
|
2013
Q3 | $7.92M | Buy |
223,412
+5,620
| +3% | +$199K | 1.09% | 24 |
|
|
2013
Q2 | $3.4M | Buy |
+217,792
| New | +$3.4M | 0.58% | 69 |
|